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Abstract 
Patients with chronic hematological malignancies must cope with multiple challenges over time. This study 
describes coping strategies, defense mechanisms, and emotional response to oncological diagnosis (depressive 
symptoms and anxiety) of patients with chronic myeloid leukemia and chronic lymphocytic leukemia as part of 
an original complex psychosomatic model. A total of 80 patients with chronic leukemia participated in the study. 
The following psychological measurement instruments were used: Ways of Coping Questionnaire, Life Style 
Index (LSI), The Beck Depression Inventory (BDI), and State-Trait-Anxiety Inventory (STAI). In addition to the 
psychological questionnaires, the objective data of dynamics of treatment and correlation analysis between signs 
were used. The formation of adaptive behavior by patients with chronic leukemia is based on the interaction of 
coping/seeking solutions with the defense mechanisms of escape/avoidance and denial. The level of trait and 
state anxiety in patients with chronic leukemia does not exceed the standard values. Depressive syndromes reach 
moderate levels in patients with chronic leukemia.  A strong correlation between somatic and psychological data 
was revealed. Results of this study extend previous findings by showing that the level of depression may play a 
significant role in the dynamics of treatment.  
 2013 The Authors. Published by Elsevier Ltd. 
Selection and/or peer-review under responsibility of Russian Psychological Society. 
Key words: Cancer, chronic leukemia, coping, defense mechanisms, depression, anxiety, psychosomatic models 
of disease 
                                                          
* Corresponding author. Tel.: +7-952-249-84-20. 
E-mail address: es.psy.pu@gmail.com 
©  The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-ND license.
S l ti n and/or peer-review under r sponsibility of Russian Psychologi al S ciety
Available online at www.sciencedirect.com
ScienceDirect
249 Ekaterina Stepanchuk et al. /  Procedia - Social and Behavioral Sciences  86 ( 2013 )  248 – 255 
1. Introduction  
 
The cause of chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL) may be a 
disruption in the composition and structure of the chromosome apparatus as genetically caused by the influence 
of certain mutagens.  
Any diagnosis of cancer carries tremendous social, emotional, and physical challenges [1], [2], [3], [4]. 
However, chronic hematological disease that carries a deadly threat and affects social status causes psychological 
distress, depression, and high anxiety levels. 
Major depression is one of the most important psychiatric disorders in the cancer population [5]. The 
prevalence of a major depressive episode has been found to range from a minimum of 5% or 6% [6] to more than 
40% [7]. This variability in prevalence can be attributed to pati
(ambulatory vs hospitalized cancer patients) or different cancer sites. Beyond characteristics of the disease, there 
experience. In particular, distress may r
mechanisms of psychological defense [8] [9]. Several 
studies have examined style of coping as a predictor of cancer outcomes. Akechi et al [9] found that a 
helpless/hopeless style of coping predicted psychological distress among lung cancer patients. Faller et al [10], 
[11] showed that a coping style consisting of brooding, arguing with fate, pitying oneself, taking it out on others, 
and social withdrawal was associated with less hope and greater depression and with shorter survival.  
Lazarus and Folkman [12] 
manage specific external and/or internal demands that are appraised as taxing or exceeding the resources of the 
Others consider coping behavior as conscious strategies of coping with disturbing events, generating the 
adaptive capacity of the personality [13]. 
However, there are unconscious mental processes that help to minimize negative experiences. Hall and 
Lindsey distinguish two main characteristics of defense mechanisms: denial or distortion of reality and action at 
the subconscious level [14]. Sammallahti et al [8] showed that the intensity of defense mechanisms in cancer 
patients was higher than that in healthy controls. 
Dysfunctional coping mechanisms of hopelessness and anxious preoccupation recently have been found to 
relate to psychosocial morbidity of cancer patients [15] and abnormal illness behavior to many measures of 
maladaptive coping, psychological distress, and psychiatric diagnoses in cancer patients [16] as well as high-
tension defense mechanisms [17]. 
The purpose of this investigation is to describe coping strategies and defense mechanisms among people 
with chronic myeloid leukemia and lymphocytic leukemia and relationships between them as a part of a complex 
psychosomatic model. We also examined the association of coping patterns and mechanisms with the intensity of 
depressive symptoms and anxiety. In particular, using regression models, we investigated particular depressive 
symptoms in predicting the number of blast cells after controlling for several characteristics.  
 
2. Metods 
 
2.1. Participants 
 
The study was conducted at Almazov Federal Heart, Blood and Endocrinology Centre, Hemotological 
Unit, and St Petersburg State Medical University of IP Pavlov, Hemotological Unit (Saint-Petersburg, Russia) 
between August 2011 and August 2012. The inclusion criteria were an age of between 18 and 72 years, diagnosis 
of chronic myeloid leukemia or lymphocytic leukemia within 6 months prior to the study, with no significant 
cognitive impairment, no symptoms suggesting major psychopathology, such as psychosis or organic mental 
disorders. All patients received standard chemotherapy and no other therapy during the study. All patients were 
consecutively recruited and invited to participate, and all signed an informed consent for the study. Out of the 
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original group of consecutive patients, those who were unable to complete the questionnaire (owing to disability) 
were excluded from this study. 
 
2.2. Assessment 
 
Patients completed a brief questionnaire including basic information related to gender, age, education, and 
duration of the cancer in terms of time elapsed since the diagnosis. 
Coping (Ways of Coping Questionnaire). The questionnaire has 50 statements concerning behavior in 
difficult situations. The participant has to evaluate how often he acts according to certain patterns of behavior. 
The method is designed to determine the coping mechanisms. The technique was developed by Lazarus and 
Folkman in 1988.  
Psychological defense mechanisms. The Life Style Index (LSI) includes 92 items measuring eight types 
of defense mechanisms: denial, displacement, repression, compensation, reaction formation, projection, 
rationalization, and regression.   
Depression. The Beck Depression Inventory (BDI) is a 21-item self-report measure of depression that is 
widely used in health behavior research [18].  
Anxiety. Anxiety was measured using the State-Trait-Anxiety Inventory (STAI) [19]. The STAI consists 
of 40 short affirmative statements divided into two distinct constructs: a transitory emotional state at a particular 
 ).  
In addition to the psychological questionnaires, the authors used the objective data of dynamics of 
treatment, eg, evaluating the level of blasts in the myelogram as well as lymphocytes and leukocytes in the blood 
and inflammation signs (C-reactive protein).  
 
2.3. Statistical Analysis  
 
Means and standard deviations were used to describe the sample demographics and test scores. Subgroup 
comparisons were run by the t-test.  
Zero-order correlations were computed to examine the simple relationships among demographic and 
medical characteristics, defense mechanisms, coping, and level of anxiety and depressive symptoms. 
To assess simultaneously the relationships between all measured variables, we employed path analysis 
in the context of structural equation modeling (SEM). As an analytic method, SEM is state-of-the-art for 
examining simultaneous relations among groups of variables. It also employs a causal framework in which one or 
more variables must be modeled as under the influence of others. In this regard, it is no different than a t-test or a 
regression analysis, both of which are special cases of SEM. In this study, although we explored a pattern of 
possible causal relations among coping, psychological defenses, and symptoms of depression and anxiety, the 
focus of our analysis was on the simultaneous relations among these variables and not on establishing causal 
precedence among them (excluding the effect of psychological variables on the reduction of leukocytes and blast 
cells). 
Data analyses were conducted using SPSS for Windows, version 17.0, and alpha was set at 0.05, two-tailed for 
all analyses. 
 
3. Results 
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Eighty cancer outpatients remained from the original group and were contacted (demographic and medical 
characteristics are displayed in Table 1). Psychological defense mechanisms and coping strateges were not 
related to age, gender, and education. 
 
Table 1. Demographic and medical characteristics 
 
Demographic and medical 
characteristics N=80 
Age 51.95 (SD=11.57) 
Male 62,5% (50) 
Female  37,5% (30) 
Married or living together 
(vs not married) 51,25% (41) 
High school education or less 52,5% (42) 
CLL (chronic lymphocytic leukemia) 57,5% (46) 
CML (chronic myeloid leukemia) 42,5% (34) 
 
 
Descriptive statistics of the psychological characteristics are reflected in Table 2.  
 
Table 2. Psychological characteristics 
 
 N Minimum Maximum Mean SD 
Beck Depression Inventory 80 3 30 14,47 8,167 
Confrontive coping 80 28 83 51,38 15,760 
Distancing 80 28 89 55,22 14,335 
Self-controlling 80 38 86 66,59 13,548 
Seeking social support 80 16 94 70,99 19,147 
Accepting responsibility 80 17 92 58,34 22,672 
Escape-Avoidance 80 21 85 68,03 18,072 
Planful problem-solving 80 11 89 58,94 21,324 
Positive reappraisal 80 33 80 67,35 18,154 
State anxiety 80 21 65 38,63 12,166 
Trait anxiety 80 25 56 40,47 8,752 
Denial 80 13 99 66,00 30,035 
Repression 80 8 92 56,05 25,763 
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Regression 80 19 97 68,37 26,239 
Compensation 80 5 97 45,68 17,681 
Projection 80 4 99 51,47 33,641 
Displacement 80 6 93 47,53 29,245 
Rationalization 80 6 95 52,68 25,124 
Reaction formation 80 19 99 61,84 28,320 
N of valid 80     
 
The data obtained show that in patients with chronic leukemia, the severity of depressive syndromes is up 
to moderate levels (a score of 19 to 29). However, the difference between mean in groups with CML and CLL for 
this indicator has not been identified. On the other hand, the number of patients with CML with a high severity of 
depressive symptoms was significantly higher than in the group with a diagnosis of CLL: 41.7% vs 28.6%, 
respectively (P < .01It is difficult to explain the difference in the framework of the classical psychological 
approach., as the perceived vital threat from both CML and CLL should be evaluated by the individual equally in 
the psychological sense. Therefore, we analyzed the relationship of psychological and biological parameters of 
patients within these nosological groups. 
We found no effect of type of disease on the formation of coping behavior of patients. The most common 
coping strategies of patients with chronic leukemia are escape-avoidance, seeking social support, and self-
control. Seeking social support reflects the active role of patients in relation to the situation of the disease, the 
search for external resources to overcome it. Self-control implies that patients rationally assess the situation of the 
disease by suppressing their emotional impulses. 
The level of trait and state anxiety in patients with chronic leukemia does not exceed the standard values 
for the health group and corresponds to a moderate level of anxiety. However, according to the available research 
data, the average level of anxiety in cancer patients varies between 44 and 51 points [20]. This is significantly 
higher than our results (state anxiety, 38.6; trait anxiety, 40.5; P < .01). Importantly, the significant differences 
between CML and CLL indicators of anxiety were not found. 
The most common defense mechanisms in patients with chronic leukemia are denial, regression, and 
reaction formation. These mechanisms are protective/primitive and prevent the flow of conflict and traumatic 
information into consciousness, and therefore distort perception of reality. 
Comparative analysis of the participants from the control group showed that cancer patients expressed the 
following psychological defense mechanisms to a greater degree: repression, regression, and reaction formation 
(significant at P < .01). That is, they are characterized by inertia, passivity, avoidance, and withdrawal and tend 
to be dependent on others. 
It was found that the regression is expressed more significantly in patients with CML (75.27 points) than 
in patients with CLL (58.87 points; P < .001). Thus, patients with CML were characterized by the use of simple 
and familiar behavior patterns, which significantly dilutes their potential for adjustment in conflict situations. 
 
3.2. Correlational Analysis 
 
We calculated correlations between coping strategies and defense mechanisms to determine the protective 
potential of the individual patients. It was found that denial is positively associated with coping escape-avoidance 
(r = 0.643; P < .01) and planful problem solving (r = 0.499; P < .05). Negative relationships between 
compensation and planful problem solving  and positive reappraisal (r = 0.500; P < .01) in 
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view of their low intensity show a not significant enough contribution of these mechanisms in the adaptive 
capacity of patients with CML and CLL. 
State and trait anxiety correlated negatively with positive reappraisal coping and seeking social support. A strong 
positive relationship between repression and trait anxiety reflects the formation of emotional personality 
characteristics of patients. 
Severity of depressive symptoms positively correlated with intense of primitive psychological defense 
mechanisms: regression and reaction formation. This indicates a low protective function of these mechanisms in 
the condition of vital threat. On the other hand, the level of depression negatively correlated with seeking social 
support and denial. 
It should be mentioned that the highest correlation between psychological and somatic parameters for 
CLL and CML patients was different. The closest correlation for CLL patients was found between psychological 
signs and lymphocytes amount; for CML patients, the closest correlation was found between psychological signs 
and a number of leukocytes. The interaction between psychological and inflammation signs was high in both 
groups. 
 
4. Discussion 
 
In this study, we assumed that the adaptive capacity of the personality is formed from two psychological 
protective systems of personality: coping strategies and defense mechanisms [21]. Correlation analysis showed 
that the mechanisms for coping with stress, as well as psychological defense mechanisms, are in a close 
relationship: the expression of specific coping strategies correlates with the severity of certain types of 
psychological defense. Thus, the most primitive psychological defense denial is associated with coping 
seeking solution and escape-avoidance. We contend that the formation of adaptive behavior in the case of 
patients with chronic leukemia is based on the interaction of these mechanisms. 
The results of this study may be construed as a model of emotional response to disease among patients 
with chronic leukemia. 
The negative relationship between depression and anxiety and the highest-level defense mechanisms, of 
denial and coping seeking social support and escape-avoidance reflects a high adaptive potential reaction to the 
disease in patients with CML and CLL. This data is consistent with the notion that mechanisms such as 
avoidance and denial are not associated with negative emotional consequences, decreased self-esteem, and 
adaptation to the deterioration caused by the disease [9], [10].   
At the same time, we believe that seeking social support coping is the most effective and helps to reduce 
anxiety and depressive symptoms or prevents their development. This is consistent with other studies in the field 
of psychooncology [22], [23]. 
 Despite the fact that this study revealed insignificant differences in the types of adjustment to cancer in 
patients in the groups with various forms of chronic leukemia, it is important to note that it was found in our 
previous studies that subjective well-being depended on the tumor location and activity or morphology. We have 
previously found that the group of hematological malignance patients (eg, malignant lymphoma, chronic 
leukemia) has a maladaptive system attitude to the disease compared with the group of patients with solid tumors 
(eg, gynecological cancer). This data suggests further investigation for a better understanding of the process of 
adaptation to cancer in its various forms [24]. 
The additional aim of our research was to investigate the influence of psychological features of Russian 
patients on important to mention 
psychotherapy. As the main characteristic of the process of chronic leukemia treatment, we considered the level 
of reduction of blast cells. Our assumptions are confirmed by data of regression analysis, according to which low 
levels of depression can be considered a predictor of successful treatment of chronic leukemia 0.45; P < 
.001; F (8, 191) = 10.78; P < .01).  
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In conclusion, the relationship between depression severity and the level of reduction of the blast cells in 
the treatment of chronic leukemia reflects the importance of screening the emotional distress among 
oncohematological patients. These results remind us that patient distress is a real issue among chronic leukemia 
patients and that part of a comprehensive cancer treatment should also include psychological interventions to 
alleviate the distress of lymphoma patients. 
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